Clinical Trial

Breast Cancer Exercise Intervention Study

Study acronym: BREXINT
Recruiting
View on ClinicalTrials.gov →
Summary
This is a 24-week exercise programme consisting of aerobic exercise and muscle strength training, 3 sessions per week. The first 9 sessions are supervised by physiotherapists in person, followed by 63 sessions monitored remotely (video) or supervised by trainers at ActiveSG (Sport Singapore) gyms.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2023-07-19; most recent amendment 2025-09-03.
Trial Details
NCT Number NCT05957068
Lead Sponsor National Cancer Centre, Singapore
Collaborators: Singapore Cancer Society, Genome Institute of Singapore, National University of Singapore, Singapore General Hospital
Conditions Early-stage Breast Cancer, Locally Advanced Breast Cancer
Enrollment 2,156 participants
Start Date 2023-07-01
Primary Completion 2028-05-31 (estimated)
Study Completion 2033-05-31 (estimated)
Updated on ClinicalTrials.gov 2025-09-05